Juanying Xu (Junying Xu)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Advanced Non Small Cell Lung Cancer

Atomic Force Microscopy

Gene Expression

Top Venues

International journal of general medicine

BioMed research international

Pharmacogenomics and personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Honghong Fan, Yuxin Shi, Huiyu Wang, Yuting Li, Jie Mei, Juanying Xu, Chaoying Liu
GBP5 Identifies Immuno-Hot Tumors and Predicts the Therapeutic Response to Immunotherapy in NSCLC. International journal of general medicine 16 (2023)
Wei Huang, Zhengtao Qian, Yuxin Shi, Zheming Zhang, Rui Hou, Jie Mei, Juanying Xu, Junli Ding
PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer. Pharmacogenomics and personalized medicine 16 (2023)
Honghong Fan, Yuxin Shi, Huiyu Wang, Yuting Li, Jie Mei, Juanying Xu, Chaoying Liu
GBP5 Identifies Immuno-Hot Tumors and Predicts the Therapeutic Response to Immunotherapy in NSCLC. International journal of general medicine 16 (2023)
Junli Ding, Hao Wang, Rui Hou, Yuxin Shi, Honghong Fan, Yuting Li, Jie Mei, Qinglin Zhang, Tingyan Ruan, Juanying Xu
Total T Cell Density and Expression of T Memory Stem Cell Markers are Associated with Better Prognosis in Colon Cancer. International journal of general medicine 16 (2023)
Jie Mei, Honghong Fan, Jiaofeng Zhou, Dingwei Huang, Juanying Xu, Yichao Zhu
Pan-cancer analysis revealing DAAM1 as a novel predictive biomarker for PD-1/PD-L1 blockade in clear cell renal cell carcinoma. MedComm 3 (4) (2022)
Jie Mei, Huiyu Wang, Runjie Wang, Jiadong Pan, Chaoying Liu, Juanying Xu
Evaluation of X-Ray Repair Cross-Complementing Family Members as Potential Biomarkers for Predicting Progression and Prognosis in Hepatocellular Carcinoma. BioMed research international 2020 (2020)